Simplified <sup>89</sup>Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells
In this work, a method for the preparation of the highly lipophilic labeling synthon [<sup>89</sup>Zr]Zr(oxinate)<sub>4</sub> was optimized for the radiolabeling of liposomes and human induced pluripotent stem cells (hiPSCs). The aim was to establish a robust and reliable lab...
Saved in:
Main Authors: | Andras Polyak (Author), Jens P. Bankstahl (Author), Karen F. W. Besecke (Author), Constantin Hozsa (Author), Wiebke Triebert (Author), Rajeswara Rao Pannem (Author), Felix Manstein (Author), Thomas Borcholte (Author), Marcus Furch (Author), Robert Zweigerdt (Author), Robert K. Gieseler (Author), Frank M. Bengel (Author), Tobias L. Ross (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
by: Helen Damerow, et al.
Published: (2022) -
Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with <sup>89</sup>Zr Radioisotope in Mice and Rats
by: Hojun Choi, et al.
Published: (2022) -
Therapeutic Response Monitoring with <sup>89</sup>Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models
by: Minwoo Kang, et al.
Published: (2022) -
Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE
by: Asif Noor, et al.
Published: (2024) -
Good practices for 89Zr radiopharmaceutical production and quality control
by: Thomas Erik Wuensche, et al.
Published: (2024)